https://pittplusme.org/study/1367
HCC 18-040
We're sorry. This study is closed and no longer recruiting participants.
STUDY BASICS
Have you been diagnosed with relapsed (comes back) or refractory (did not get better) multiple myeloma? If so, you may be eligible to participate in a study to help researchers test whether an investigational (experimental) drug called venetoclax combined with dexamethasone works better than the combination of pomalidomide and dexamethasone to treat multiple myeloma. Compensation provided.
IRB: 20181482
- A Phase 3, Multicenter, Randomized, Open Label Study of Venetoclax and Dexamethasone Compared with Pomalidomide and Dexamethasone in Subjects with t(11;14)-Positive Relapsed or Refractory Multiple Myeloma
AGE:
18 and up
LOCATION:
UPMC Cancer Center
COMPENSATION:
$56.00 per completed visit
SHARE STUDY
